International Congress of Ayurveda: Relief from exploding health costs. The International Congress of Ayurveda, the biggest ever in Europe, brought together 400 participants from 40 countries, including medical doctors, health-administration professionals and three top-ranking representatives of the Indian government. The Congress ended on April 12th in Roermond, Holland after two days of discussing ways in which Ayurveda, the worlds most ancient medical system, can turn back the exploding costs of healthcare through natural treatments and disease prevention.International Congress of Ayurveda

Relief from exploding health costs

 

Roermond, Netherlands (April 11, 2015) – The International Congress of Ayurveda, the biggest ever in Europe, brought together 400 participants from 40 countries, including medical doctors, health-administration professionals and three top-ranking representatives of the Indian government. The Congress ended on April 12th in Roermond, Holland after two days of discussing ways in which Ayurveda, the world’s most ancient medical system, can turn back the exploding costs of healthcare through natural treatments and disease prevention.


Professor Subhash Ranade, leading Ayurvedic expert and co-organizer of the Congress, summed up
its conclusions: “No health system can recognize as early as Ayurveda when the balance of the body is in danger. On this basis we can intervene consultatively and therapeutically, long before difficult-to-treat symptoms appear.”

 

Main organizer of the Congress was the International Maharishi Ayurveda Foundation, with the collaboration of the All India Ayurvedic Congress, the largest Ayurveda organisation worldwide (350,000 members, founded 1907), and with the young International Academy of Ayurveda from Pune, India (founded 1996).

 

 

WHO on lifestyle diseases: “Silent, secret killers”

 

The World Health Organisation (WHO) calls modern lifestyle diseases “silent, secret killers” with 38 million fatalities in 2012 alone. The worldwide economic losses are in the trillions. Prof. Ranade: “Alzheimer’s disease, arthritis, atherosclerosis, asthma, some kinds of cancer, chronic liver disease or cirrhosis, chronic obstructive pulmonary disease, type 2 diabetes, heart disease, metabolic syndrome, chronic renal failure, osteoporosis, stroke, depression and obesity are actually lifestyle diseases.”

 

Dr. med. Ulrich Bauhofer, leading German Ayurvedic doctor and book author, said during his talk: “Modern lifestyle diseases are strangling our healthcare system. Let’s position nature instead – before machines and pills are getting unaffordable. The success of Ayurveda is remarkable and cost-cutting.”

 

Dr. Karin Pirc, medical director of an Ayurvedic clinic in Bad Ems, Germany: “The results of the scientific research on Ayurveda are so promising that we can’t afford to ignore them any longer.”

 

 

Rethinking process

 

Several developments show that this rethinking is going on: In 1996 the Hufeland Society, a German umbrella organisation for naturopathy, evaluated the preventive approach of Ayurveda very positively, not only because of its cost-efficiency, but also because of its scientific character.

 

Some months ago the Indian government established a Ministry for Yoga and Ayurveda. They even suggest the adoption of yoga and meditation as part of teacher training. Last year the German government adopted a draft of a new prevention law. “This is a step in the right direction”, said Dr. Bauhofer. “Prevention must become the new guiding principle of our healthcare policy. Worldwide.”

 

 

Links

 

 

 


International Ayurveda Congress, April 10 – 14, 2015, Roermond, The Netherlands (tB).

MEDICAL NEWS

New guidance to prevent the tragedy of unrecognized esophageal intubation
Overly restrictive salt intake may worsen outcomes for common form…
COVID-19 vaccines are estimated to have prevanented 20 million deaths…
Novel sleep education learning modules developed for nurse practitioners
Scientists discover how salt in tumours could help diagnose and…

SCHMERZ PAINCARE

Aktuelle Versorgungssituation der Opioidtherapie im Fokus
Individuelle Schmerztherapie mit Opioiden: Patienten im Mittelpunkt
Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…

DIABETES

Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Kaltplasma bei diabetischem Fußsyndrom wirkt via Wachstumsfaktoren
Typ-1-Diabetes: InRange – auf die Zeit im Zielbereich kommt es…

ERNÄHRUNG

Gesunde Ernährung: „Nicht das Salz und nicht das Fett verteufeln“
Mangelernährung gefährdet den Behandlungserfolg — DGEM: Ernährungsscreening sollte zur klinischen…
Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?

ONKOLOGIE

Nahrungsergänzungsmittel während der Krebstherapie: Es braucht mehr Bewusstsein für mögliche…
Fusobakterien und Krebs
Fortgeschrittenes Zervixkarzinom: Pembrolizumab verlängert Leben
Krebspatienten unter Immuntherapie: Kein Hinweis auf erhöhtes Risiko für schwere…
Aktuelle Kongressdaten zum metastasierten Mammakarzinom und kolorektalen Karzinom sowie Neues…

MULTIPLE SKLEROSE

Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?
Neuer Therapieansatz für Multiple Sklerose und Alzheimer
„Ich messe meine Multiple Sklerose selbst!“ – Digitales Selbstmonitoring der…

PARKINSON

Alexa, bekomme ich Parkinson?
Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…